Cardiotonic agent: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz No edit summary |
imported>Howard C. Berkowitz No edit summary |
||
| Line 2: | Line 2: | ||
{{TOC|right}} | {{TOC|right}} | ||
In [[medicine]] and [[pharmacology]], '''cardiotonic agents''' are "agents that have a strengthening effect on the heart or that can increase cardiac output. They may be [[cardiac glycoside]]s; [[sympathomimetic]]s; or other drugs. They are used after [[myocardial infarction|myocardial infarct]]; cardiac surgical procedures; in shock; or in congestive heart failure ([[heart failure]])."<ref>{{MeSH}}</ref> | In [[medicine]] and [[pharmacology]], '''cardiotonic agents''' are "agents that have a strengthening effect on the heart or that can increase cardiac output. They may be [[cardiac glycoside]]s; [[sympathomimetic]]s; or other drugs. They are used after [[myocardial infarction|myocardial infarct]]; cardiac surgical procedures; in shock; or in congestive heart failure ([[heart failure]])."<ref>{{MeSH}}</ref> | ||
==Examples== | |||
== | ===[[sympathomimetic]] cardiotonic agents=== | ||
{{r|Dobutamine}} | {{r|Dobutamine}} | ||
{{r|Dopamine}} | {{r|Dopamine}} | ||
| Line 10: | Line 10: | ||
{{r|Norepinephrine}} | {{r|Norepinephrine}} | ||
== | ===[[cardiac glycoside]]s cardiotonic agents=== | ||
{{r|Digoxin}} | {{r|Digoxin}} | ||
== | ===[[phosphodiesterase inhibitor]]s cardiotonic agents=== | ||
{{r|Milrinone}} | {{r|Milrinone}} | ||
==Indications and contraindications== | |||
Other than perhaps to buy time during corrective surgery, drugs have a limited role in maintaining blood pressure as long as uncorrected trauma, obstruction to perfusion, and hemorrhage exists. | |||
==References== | ==References== | ||
<references/> | <references/> | ||
Latest revision as of 11:27, 12 June 2010
In medicine and pharmacology, cardiotonic agents are "agents that have a strengthening effect on the heart or that can increase cardiac output. They may be cardiac glycosides; sympathomimetics; or other drugs. They are used after myocardial infarct; cardiac surgical procedures; in shock; or in congestive heart failure (heart failure)."[1]
Examples
sympathomimetic cardiotonic agents
- Dobutamine [r]: A beta-2 agonist catecholamine that has cardiac stimulant action without evoking vasoconstriction or tachycardia; it is proposed as a cardiotonic after myocardial infarction or open heart surgery, and used as a pharmacological stressor in cardiac stress testing. [e]
- Dopamine [r]: A monoamine neurotransmitter formed in the brain by the decarboxylation of dopa and essential to the normal functioning of the central nervous system. [e]
- Epinephrine [r]: A hormone (adrenalin) adrenergic systems-stimulator used in asthma and cardiac failure. [e]
- Isoproterenol [r]: Isopropyl analog of epinephrine; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. [e]
- Norepinephrine [r]: Precursor of epinephrine that is secreted by the adrenal medulla and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers and of the diffuse projection system in the brain arising from the locus ceruleus. It is also found in plants and is used pharmacologically as a sympathomimetic. [e]
cardiac glycosides cardiotonic agents
- Digoxin [r]: The most commonly used synthetic derivative of digitalis glycosides, used clinically to improve the pumping action of the heart [e]
phosphodiesterase inhibitors cardiotonic agents
- Milrinone [r]: A positive inotropic cardiotonic agent with vasodilator properties; inhibits cAMP phosphodiesterase activity in myocardium and vascular smooth muscle; is a derivative of amrinone and has 20-30 times the ionotropic potency of amrinone. [e]
Indications and contraindications
Other than perhaps to buy time during corrective surgery, drugs have a limited role in maintaining blood pressure as long as uncorrected trauma, obstruction to perfusion, and hemorrhage exists.
References
- ↑ Anonymous (2024), Cardiotonic agent (English). Medical Subject Headings. U.S. National Library of Medicine.